R. Sasisekharan and G. Venkataraman, Heparin and heparan sulfate: biosynthesis, structure and function, Current Opinion in Chemical Biology, vol.4, issue.6, pp.626-631, 2000.
DOI : 10.1016/S1367-5931(00)00145-9

M. Morimoto-tomita, K. Uchimura, Z. Werb, S. Hemmerich, and S. Rosen, Cloning and Characterization of Two Extracellular Heparin-degrading Endosulfatases in Mice and Humans, Journal of Biological Chemistry, vol.277, issue.51, pp.49175-49185, 2002.
DOI : 10.1074/jbc.M205131200

C. Holst, H. Bou-reslan, B. Gore, K. Wong, D. Grant et al., Secreted Sulfatases Sulf1 and Sulf2 Have Overlapping yet Essential Roles in Mouse Neonatal Survival, PLoS ONE, vol.7, issue.6, p.575, 2007.
DOI : 10.1371/journal.pone.0000575.s006

I. Kalus, B. Salmen, C. Viebahn, V. Figura, K. Schmitz et al., Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity, Journal of Cellular and Molecular Medicine, vol.18, issue.11-12, pp.4505-4521, 2009.
DOI : 10.1111/j.1582-4934.2008.00558.x

D. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally et al., ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform, Neoplasia, vol.6, issue.1, pp.1-6, 2004.
DOI : 10.1016/S1476-5586(04)80047-2

S. Assou, L. Carrour, T. Tondeur, S. Strom, S. Gabelle et al., A Meta-Analysis of Human Embryonic Stem Cells Transcriptome Integrated into a Web-Based Expression Atlas, Stem Cells, vol.22, issue.4, pp.961-973, 2007.
DOI : 10.1634/stemcells.2006-0352
URL : https://hal.archives-ouvertes.fr/inserm-00128925

A. Elfilali, S. Lair, C. Verbeke, L. Rosa, P. Radvanyi et al., ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis, Nucleic Acids Research, vol.34, issue.90001, pp.613-616, 2006.
DOI : 10.1093/nar/gkj022

J. Lai, J. Chien, J. Staub, R. Avula, E. Greene et al., Loss of HSulf-1 Up-regulates Heparin-binding Growth Factor Signaling in Cancer, Journal of Biological Chemistry, vol.278, issue.25, pp.23107-23117, 2003.
DOI : 10.1074/jbc.M302203200

J. Staub, J. Chien, Y. Pan, X. Qian, K. Narita et al., Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance, Oncogene, vol.94, issue.34, pp.4969-4978, 2007.
DOI : 10.1038/sj.onc.1210300

P. Liu, A. Khurana, R. Rattan, X. He, S. Kalloger et al., Regulation of HSulf-1 Expression by Variant Hepatic Nuclear Factor 1 in Ovarian Cancer, Cancer Research, vol.69, issue.11, pp.4843-4850, 2009.
DOI : 10.1158/0008-5472.CAN-08-3065

J. Lai, J. Thompson, D. Sandhu, and L. Roberts, Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets, Future Oncology, vol.4, issue.6, pp.803-814, 2008.
DOI : 10.2217/14796694.4.6.803

Z. Chen, J. Fan, J. Li, Q. Li, Z. Yan et al., silencing in human breast and gastric cancer, International Journal of Cancer, vol.10, issue.3, pp.739-744, 2009.
DOI : 10.1002/ijc.23960

H. Zhao, C. Ramos, J. Brooks, and D. Peehl, Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues, Journal of Cellular Physiology, vol.62, issue.1, pp.111-121, 2007.
DOI : 10.1002/jcp.20828

J. Lai, J. Chien, S. Strome, J. Staub, D. Montoya et al., HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma, Oncogene, vol.23, issue.7, pp.1439-1447, 2004.
DOI : 10.1038/sj.onc.1207258

X. Ai, T. Kitazawa, A. Do, M. Kusche-gullberg, P. Labosky et al., SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation, Development, vol.134, issue.18, pp.3327-3338, 2007.
DOI : 10.1242/dev.007674

A. Langsdorf, A. Do, M. Kusche-gullberg, C. Emerson, and A. X. Jr, Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration, Developmental Biology, vol.311, issue.2, pp.464-477, 2007.
DOI : 10.1016/j.ydbio.2007.08.053

W. Lamanna, M. Frese, M. Balleininger, and T. Dierks, Sulf Loss Influences N-, 2-O-, and 6-O-Sulfation of Multiple Heparan Sulfate Proteoglycans and Modulates Fibroblast Growth Factor Signaling, Journal of Biological Chemistry, vol.283, issue.41, pp.27724-27735, 2008.
DOI : 10.1074/jbc.M802130200

J. Lai, J. Chien, D. Moser, J. Staub, I. Aderca et al., hSulf1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling, Gastroenterology, vol.126, issue.1, pp.1231-248, 2004.
DOI : 10.1053/j.gastro.2003.09.043

K. Narita, J. Chien, S. Mullany, J. Staub, X. Qian et al., Loss of HSulf-1 Expression Enhances Autocrine Signaling Mediated by Amphiregulin in Breast Cancer, Journal of Biological Chemistry, vol.282, issue.19, pp.14413-14420, 2007.
DOI : 10.1074/jbc.M611395200

Y. Dai, Y. Yang, V. Macleod, X. Yue, A. Rapraeger et al., HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor Growth in Vivo, Journal of Biological Chemistry, vol.280, issue.48, pp.40066-40073, 2005.
DOI : 10.1074/jbc.M508136200

K. Narita, J. Staub, J. Chien, K. Meyer, M. Bauer et al., HSulf-1 Inhibits Angiogenesis and Tumorigenesis In vivo, Cancer Research, vol.66, issue.12, pp.6025-6032, 2006.
DOI : 10.1158/0008-5472.CAN-05-3582

J. Lai, C. Yu, C. Moser, I. Aderca, T. Han et al., SULF1 Inhibits Tumor Growth and Potentiates the Effects of Histone Deacetylase Inhibitors in Hepatocellular Carcinoma, Gastroenterology, vol.130, issue.7, pp.12130-2144, 2006.
DOI : 10.1053/j.gastro.2006.02.056

J. Lai, D. Sandhu, C. Moser, S. Cazanave, A. Oseini et al., Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo, Journal of Hepatology, vol.50, issue.6, pp.1112-1121, 2009.
DOI : 10.1016/j.jhep.2008.12.031

H. Lemjabbar-alaoui, A. Van-zante, M. Singer, Q. Xue, Y. Wang et al., Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis, Oncogene, vol.19, issue.5, pp.635-646
DOI : 10.1038/sj.onc.1207844

J. Sethi and A. Vidal-puig, Wnt signalling and the control of cellular metabolism, Biochemical Journal, vol.17, issue.1, pp.1-17
DOI : 10.2337/db08-1770

M. Morimoto-tomita, K. Uchimura, A. Bistrup, D. Lum, M. Egeblad et al., Sulf-2, a Proangiogenic Heparan Sulfate Endosulfatase, Is Upregulated in Breast Cancer, Neoplasia, vol.7, issue.11, pp.1001-1010, 2005.
DOI : 10.1593/neo.05496

C. Bret, D. Hose, T. Reme, A. Sprynski, K. Mahtouk et al., Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells, British Journal of Haematology, vol.13, issue.Suppl, pp.350-368, 2009.
DOI : 10.1111/j.1365-2141.2009.07633.x
URL : https://hal.archives-ouvertes.fr/inserm-00371535

F. Zhan, Y. Huang, S. Colla, J. Stewart, I. Hanamura et al., The molecular classification of multiple myeloma, Blood, vol.108, issue.6, pp.2020-2028, 2006.
DOI : 10.1182/blood-2005-11-013458

A. Sprynski, D. Hose, L. Caillot, T. Reme, J. Shaughnessy et al., The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor, Blood, vol.113, issue.19, pp.4614-4626, 2009.
DOI : 10.1182/blood-2008-07-170464
URL : https://hal.archives-ouvertes.fr/inserm-00367812

J. Shaughnessy, . Jr, F. Zhan, B. Burington, Y. Huang et al., A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 110, Blood, vol.1182, issue.109, pp.2276-2284, 2007.

D. Hose, T. Reme, T. Hielscher, J. Moreaux, T. Messner et al., Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma, Haematologica, vol.96, issue.1, pp.87-95, 2011.
DOI : 10.3324/haematol.2010.030296

O. Decaux, L. Lode, F. Magrangeas, C. Charbonnel, W. Gouraud et al., Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du My??lome, Journal of Clinical Oncology, vol.26, issue.29, pp.4798-4805, 2008.
DOI : 10.1200/JCO.2007.13.8545

J. Moreaux, D. Hose, T. Reme, J. E. Hundemer, M. Legouffe et al., CD200 is a new prognostic factor in multiple myeloma, Blood, vol.108, issue.13, pp.2004194-4197, 2006.
DOI : 10.1182/blood-2006-06-029355
URL : https://hal.archives-ouvertes.fr/inserm-00130595

F. Zhan, Y. Huang, S. Colla, J. Stewart, I. Hanamura et al., The molecular classification of multiple myeloma 10, Blood, vol.1182, issue.108, pp.2020-2028, 2006.

. Bret, http://www.translational-medicine.com/content, Journal of Translational Medicine, vol.91, issue.9, p.7272, 2011.

J. Lai, D. Sandhu, C. Yu, T. Han, C. Moser et al., Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma, Hepatology, vol.6, issue.4, pp.1211-1222, 2008.
DOI : 10.1002/hep.22202

R. Nawroth, A. Van-zante, S. Cervantes, M. Mcmanus, M. Hebrok et al., Extracellular Sulfatases, Elements of the Wnt Signaling Pathway, Positively Regulate Growth and Tumorigenicity of Human Pancreatic Cancer Cells, PLoS ONE, vol.61, issue.4, p.392, 2007.
DOI : 10.1371/journal.pone.0000392.s001

F. Johansson, H. Goransson, and B. Westermark, Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice, Oncogene, vol.30, issue.24, pp.3896-3905, 2005.
DOI : 10.1038/sj.onc.1208553

E. Moussay, V. Palissot, L. Vallar, H. Poirel, T. Wenner et al., Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia, Molecular Cancer, vol.9, issue.1, p.115
DOI : 10.1186/1476-4598-9-115

S. Rosen and H. Lemjabbar-alaoui, Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate, Expert Opinion on Therapeutic Targets, vol.9, issue.9, pp.935-949, 2010.
DOI : 10.1158/1078-0432.CCR-04-1813

A. Riker, S. Enkemann, O. Fodstad, S. Liu, S. Ren et al., The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis, BMC Medical Genomics, vol.33, issue.3, p.13, 2008.
DOI : 10.1093/nar/gni027

R. Skotheim, G. Lind, O. Monni, J. Nesland, V. Abeler et al., Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development, Cancer Research, vol.65, issue.13, pp.5588-5598, 2005.
DOI : 10.1158/0008-5472.CAN-05-0153

E. Wurmbach, Y. Chen, G. Khitrov, W. Zhang, S. Roayaie et al., Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma, Hepatology, vol.28, issue.4, pp.938-947, 2007.
DOI : 10.1002/hep.21622

J. Durig, S. Bug, L. Klein-hitpass, T. Boes, T. Jons et al., Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32), Leukemia, vol.40, issue.10, pp.2153-2163, 2007.
DOI : 10.1158/1541-7786.MCR-05-0128

K. Stegmaier, K. Ross, S. Colavito, O. Malley, S. Stockwell et al., Gene expression???based high-throughput screening(GE-HTS) and application to leukemia differentiation, Nature Genetics, vol.36, issue.3, pp.257-263, 2004.
DOI : 10.1038/ng1305

M. Gumz, H. Zou, P. Kreinest, A. Childs, L. Belmonte et al., Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma, Clinical Cancer Research, vol.13, issue.16, pp.4740-4749, 2007.
DOI : 10.1158/1078-0432.CCR-07-0143

A. Bhattacharjee, W. Richards, J. Staunton, C. Li, S. Monti et al., Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses, Proceedings of the National Academy of Sciences, vol.98, issue.24, pp.13790-13795, 2001.
DOI : 10.1073/pnas.191502998

E. Huang, S. Cheng, H. Dressman, J. Pittman, M. Tsou et al., Gene expression predictors of breast cancer outcomes, The Lancet, vol.361, issue.9369, pp.1590-1596, 2003.
DOI : 10.1016/S0140-6736(03)13308-9

T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J. Marron et al., Repeated observation of breast tumor subtypes in independent gene expression data sets, Proceedings of the National Academy of Sciences, vol.100, issue.14, pp.8418-8423, 2003.
DOI : 10.1073/pnas.0932692100

I. Abiatari, J. Kleeff, J. Li, K. Felix, M. Buchler et al., Hsulf-1 regulates growth and invasion of pancreatic cancer cells, Journal of Clinical Pathology, vol.59, issue.10, pp.1052-1058, 2006.
DOI : 10.1136/jcp.2005.031716

A. Sahota and G. Dhoot, A novel SULF1 splice variant inhibits Wnt signalling but enhances angiogenesis by opposing SULF1 activity, Experimental Cell Research, vol.315, issue.16, pp.2752-2764, 2009.
DOI : 10.1016/j.yexcr.2009.06.029

B. Adamsen, K. Kravik, O. Clausen, D. Angelis, and P. , Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment, International Journal of Oncology, vol.31, pp.1491-1500, 2007.
DOI : 10.3892/ijo.31.6.1491

B. Chau, R. Diaz, M. Saunders, C. Cheng, A. Chang et al., Identification of SULF2 as a Novel Transcriptional Target of p53 by Use of Integrated Genomic Analyses, Cancer Research, vol.69, issue.4, pp.1368-1374, 2009.
DOI : 10.1158/0008-5472.CAN-08-2742

I. Vlodavsky, M. Elkin, G. Abboud-jarrous, F. Levi-adam, L. Fuks et al., Heparanase: One Molecule with Multiple Functions in Cancer Progression, Connective Tissue Research, vol.1471, issue.3-4, pp.207-210, 2008.
DOI : 10.1073/pnas.0502287102

M. Onken, L. Worley, J. Ehlers, and J. Harbour, Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death, Cancer Research, vol.64, issue.20, pp.7205-7209, 2004.
DOI : 10.1158/0008-5472.CAN-04-1750

. Bret, SULFs in human neoplasia: implication as progression and prognosis factors, Journal of Translational Medicine, vol.9, issue.1, p.72, 2011.
DOI : 10.1158/0008-5472.CAN-04-1750
URL : https://hal.archives-ouvertes.fr/inserm-00601153

. Bret, http://www.translational-medicine.com/content, Journal of Translational Medicine, vol.91, issue.9, p.7272, 2011.